Intuitive beats estimates that a rebound in surgeries boosts demand for its robots.

Intuitive Surgical beat Wall Street estimates for fourth-quarter revenue and profit, as a recovery in surgeries lifted demand for its minimally invasive robots. Medical device makers have noted the temporary impact of weight-loss drugs on sales of abdomen surgery products. Shares of Intuitive rose 7.2% to $399 in extended trading. Johnson & Johnson expects medtech-related procedures to remain elevated in 2024.

January 23, 2024
9 Articles

Further Reading